BACKGROUND: Reduced left ventricular torsion (LV-tor) has been reported to be associated with acute rejection in heart transplant (HTx) recipients. We investigated the utility of LV-tor analysis derived from 2-dimensional speckle-tracking echocardiography (2D-STE) for detecting allograft rejection. METHODS: A total of 301 endomyocardial biopsies (EMBs), right heart catheterizations and echocardiograms were performed in 32 HTx recipients. Echocardiography was done within 3 hours from EMB or simultaneously with the procedures. The LV-tor was defined as the difference between apical and basal end-systolic rotations. The LV-tor values with and without cellular rejection were compared. In addition, we investigated whether the change in LV-tor values predicts the change in rejection grade in each patient. The baseline LV-tor value in each patient was defined as a mean value of the first 3 LV-tor measurements obtained when the patient was free from rejection. RESULTS: According to the conventional International Society for Heart and Lung Transplantation criteria, 274 biopsies showed a rejection Grade of 0, 1a or 1b (Group AR(-)), whereas 27 biopsies were Grade 2 or higher (Group AR(+)). LV-tor decreased more in Group AR(+) than in Group AR(-) (9.3 ± 0.7 vs 12.2 ± 0.2 degrees, p < 0.0001). In the LV-tor measurement for each patient, the 25% reduction in LV-tor value from baseline predicted Grade 2 or higher rejection with a predictive accuracy of 92.9%. CONCLUSION: LV-tor derived from 2D-STE could be of clinical value for non-invasive monitoring of acute rejection in HTx recipients.
BACKGROUND: Reduced left ventricular torsion (LV-tor) has been reported to be associated with acute rejection in heart transplant (HTx) recipients. We investigated the utility of LV-tor analysis derived from 2-dimensional speckle-tracking echocardiography (2D-STE) for detecting allograft rejection. METHODS: A total of 301 endomyocardial biopsies (EMBs), right heart catheterizations and echocardiograms were performed in 32 HTx recipients. Echocardiography was done within 3 hours from EMB or simultaneously with the procedures. The LV-tor was defined as the difference between apical and basal end-systolic rotations. The LV-tor values with and without cellular rejection were compared. In addition, we investigated whether the change in LV-tor values predicts the change in rejection grade in each patient. The baseline LV-tor value in each patient was defined as a mean value of the first 3 LV-tor measurements obtained when the patient was free from rejection. RESULTS: According to the conventional International Society for Heart and Lung Transplantation criteria, 274 biopsies showed a rejection Grade of 0, 1a or 1b (Group AR(-)), whereas 27 biopsies were Grade 2 or higher (Group AR(+)). LV-tor decreased more in Group AR(+) than in Group AR(-) (9.3 ± 0.7 vs 12.2 ± 0.2 degrees, p < 0.0001). In the LV-tor measurement for each patient, the 25% reduction in LV-tor value from baseline predicted Grade 2 or higher rejection with a predictive accuracy of 92.9%. CONCLUSION: LV-tor derived from 2D-STE could be of clinical value for non-invasive monitoring of acute rejection in HTx recipients.
Authors: Nitin Chanana; Charlotte S Van Dorn; Melanie D Everitt; Hsin Yi Weng; Dylan V Miller; Shaji C Menon Journal: Pediatr Cardiol Date: 2017-02-04 Impact factor: 1.655
Authors: C Sciaccaluga; G E Mandoli; N Sisti; M B Natali; A Ibrahim; D Menci; A D'Errico; G Donati; G Benfari; S Valente; S Bernazzali; M Maccherini; S Mondillo; M Cameli; M Focardi Journal: Int J Cardiovasc Imaging Date: 2021-01-13 Impact factor: 2.357
Authors: Michael V Di Maria; Hao H Hsu; Ghassan Al-Naami; Jeanine Gruenwald; K Scott Kirby; Fenella J Kirkham; Sharon E Cox; Adel K Younoszai Journal: J Am Soc Echocardiogr Date: 2014-12-30 Impact factor: 5.251
Authors: Heynric B Grotenhuis; Emile C A Nyns; Paul F Kantor; Anne I Dipchand; Steven C Greenway; Shi-Joon Yoo; George Tomlinson; Rajiv R Chaturvedi; Lars Grosse-Wortmann Journal: Pediatr Cardiol Date: 2017-05-30 Impact factor: 1.655
Authors: Andrew S Tseng; Umama S Gorsi; Sergio Barros-Gomes; Fletcher A Miller; Patricia A Pellikka; Alfredo L Clavell; Hector R Villarraga Journal: BMC Cardiovasc Disord Date: 2018-12-22 Impact factor: 2.298